J Cancer 2018; 9(20):3802-3811. doi:10.7150/jca.29233 This issue Cite

Research Paper

Oestrogen Inhibits VEGF Expression And Angiogenesis In Triple-Negative Breast Cancer By Activating GPER-1

Chen Wang, Jiehao Li, Shuang Ye, Yaxing Zhang, Ping Li, Ling Wang, Ting-huai Wang

Department of Physiology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, People's Republic of China

Citation:
Wang C, Li J, Ye S, Zhang Y, Li P, Wang L, Wang Th. Oestrogen Inhibits VEGF Expression And Angiogenesis In Triple-Negative Breast Cancer By Activating GPER-1. J Cancer 2018; 9(20):3802-3811. doi:10.7150/jca.29233. https://www.jcancer.org/v09p3802.htm
Other styles

File import instruction

Abstract

Triple-negative breast cancer (TNBC) is the most malignant type of breast cancer with ample vascularisation and high vascular endothelial growth factor (VEGF) expression. The sex steroid hormone oestrogen is involved in several cellular activities associated with TNBC regulation. However, the role of oestrogen in VEGF expression and angiogenesis in TNBC remains unclear. In this study, we found that treatment with 17β-oestradiol (E2) inhibited VEGF mRNA and protein expression in the TNBC cell lines MDA-MB-468 and MDA-MB-436. To further elaborate on the phenomenon of E2-regulated angiogenesis, we showed that conditioned medium from the TNBC cell line MDA-MB-468 treated with E2 inhibits the tube formation ability of human umbilical vein endothelial cells (HUVECs). Additionally, the G-protein-coupled oestrogen receptor-1 (GPER-1)-specific agonist G-1 has a function similar to that of E2. While G-15, the selective antagonist of GPER-1, notably reversed the inhibitory effects of E2 and G-1 on VEGF expression and tube formation, suggesting that GPER-1 is involved in the E2-induced angiogenesis suppression in TNBC cells. Moreover, E2 inhibited in vivo tumour growth and angiogenesis and reduced the expression levels of VEGF, NF-κB/p65, STAT3, and the endothelial marker CD34 in MDA-MB-468 xenograft tumours. Our findings provide important evidence that E2 can inhibit VEGF expression and angiogenesis in TNBC by activating GPER-1, offering additional insight into tumour angiogenesis and targets for drug intervention in TNBC.

Keywords: oestrogen, TNBC, angiogenesis, VEGF, GPER-1


Citation styles

APA
Wang, C., Li, J., Ye, S., Zhang, Y., Li, P., Wang, L., Wang, T.h. (2018). Oestrogen Inhibits VEGF Expression And Angiogenesis In Triple-Negative Breast Cancer By Activating GPER-1. Journal of Cancer, 9(20), 3802-3811. https://doi.org/10.7150/jca.29233.

ACS
Wang, C.; Li, J.; Ye, S.; Zhang, Y.; Li, P.; Wang, L.; Wang, T.h. Oestrogen Inhibits VEGF Expression And Angiogenesis In Triple-Negative Breast Cancer By Activating GPER-1. J. Cancer 2018, 9 (20), 3802-3811. DOI: 10.7150/jca.29233.

NLM
Wang C, Li J, Ye S, Zhang Y, Li P, Wang L, Wang Th. Oestrogen Inhibits VEGF Expression And Angiogenesis In Triple-Negative Breast Cancer By Activating GPER-1. J Cancer 2018; 9(20):3802-3811. doi:10.7150/jca.29233. https://www.jcancer.org/v09p3802.htm

CSE
Wang C, Li J, Ye S, Zhang Y, Li P, Wang L, Wang Th. 2018. Oestrogen Inhibits VEGF Expression And Angiogenesis In Triple-Negative Breast Cancer By Activating GPER-1. J Cancer. 9(20):3802-3811.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image